Effects of NG‐nitro‐L‐arginine and L‐arginine on regional cerebral blood flow in the cat.
- 1 April 1992
- journal article
- Published by Wiley in The Journal of Physiology
- Vol. 449 (1) , 183-196
- https://doi.org/10.1113/jphysiol.1992.sp019081
Abstract
1. We studied the effects of NG-nitro-L-arginine (NOLA), a potent inhibitor of the L-arginine-nitric oxide pathway, and L-arginine, the precursor of nitric oxide, on regional cerebral blood flow, electrocortical activity and ex vivo cerebrovascular reactivity in the cat. Flow was measured via radiolabelled microspheres, and vascular responses were studied by measuring isometric tension of isolated middle cerebral arterial rings. 2. NOLA (30 mg kg-1 bolus followed by 1 mg kg-1 min-1 infusion) caused an approximately 40 mmHg elevation in the mean arterial blood pressure, a regionally heterogenous increase of the regional cerebrovascular resistance and a decrease in the regional cerebral blood flow 15 and 40 min after the start of its administration. In contrast L-arginine (30 mg kg-1 bolus followed by 10 mg kg-1 min-1 infusion) did not alter blood pressure, cerebrovascular resistance nor regional cerebral blood flow 15 min after the start of its administration. The NOLA-induced changes in tissue flow were the most pronounced in the cerebellum, pituitary and medulla oblongata, whereas there was no decrease in the flow of the cortex and white matter. 3. NOLA caused characteristic changes in total fronto-occipital EEG power and in power spectra which were unlikely to have been due to cerebral ischaemia. In addition, the ex vivo reactivity of the middle cerebral arteries showed signs of impaired endothelial nitric oxide synthesis: there were enhanced noradrenaline-induced contractions and N-ethoxycarbonyl-3-morpholino-sydnonimine (SIN-1)-induced relaxations and markedly attenuated acetylcholine- and ATP-induced relaxations after NOLA treatment. 4. The present data indicate that resting cerebral blood flow and cerebrovascular resistance are regulated by nitric oxide derived from L-arginine in a regionally heterogenous way and that exogenous L-arginine availability is not a limiting factor in this nitric oxide generation. Possibly, both the vascular endothelium and the neurons contribute to this basal nitric oxide release.Keywords
This publication has 35 references indexed in Scilit:
- Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo.Proceedings of the National Academy of Sciences, 1991
- Glutamate, nitric oxide and cell-cell signalling in the nervous systemTrends in Neurosciences, 1991
- l‐NG‐nitro arginine methyl ester exhibits antinociceptive activity in the mouseBritish Journal of Pharmacology, 1991
- Localization of nitric oxide synthase indicating a neural role for nitric oxideNature, 1990
- Role of nitric oxide in regulation of basilar artery tone in vivoAmerican Journal of Physiology-Heart and Circulatory Physiology, 1990
- L-arginine-induced hypotensionThe Lancet, 1990
- Kinetic characteristics of nitric oxide synthase from rat brainBiochemical Journal, 1990
- Regional distribution of EDRF/NO-synthesizing enzyme(s) in rat brainBiochemical and Biophysical Research Communications, 1990
- Identification of arginine as a precursor of endothelium-derived relaxing factor.Proceedings of the National Academy of Sciences, 1988
- Blood flow measurements with radionuclide-labeled particlesProgress in Cardiovascular Diseases, 1977